Biomolecular strategies for therapeutic intervention in cancerGIORDANO, Antonio; MAIO, Michele.Oncogene (Basingstoke). 2003, Vol 22, Num 42, issn 0950-9232, 193 p.Serial Issue

Cancer epigeneticsMOMPARLER, Richard L.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6479-6483, issn 0950-9232, 5 p.Article

Pharmacogenomics: road to anticancer therapeutics nirvana?DESAI, Apurva A; INNOCENTI, Federico; RATAIN, Mark J et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6621-6628, issn 0950-9232, 8 p.Article

Therapeutic approaches to AIDS-related malignanciesBERRETTA, Massimiliano; CINELLI, Roberta; MARTELLOTTA, Ferdinando et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6646-6659, issn 0950-9232, 14 p.Article

Epigenetic targets in hematopoietic malignanciesCLAUS, Rainer; LÜBBERT, Michael.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6489-6496, issn 0950-9232, 8 p.Article

Biologic and therapeutic role of HER2 in cancerMENARD, Sylvie; MARJA PUPA, Serenella; CAMPIGLIO, Manuela et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6570-6578, issn 0950-9232, 9 p.Article

Pathologic aspects of AIDS malignanciesBELLAN, C; DE FALCO, G; LAZZI, S et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6639-6645, issn 0950-9232, 7 p.Article

Molecular basis of angiogenesis and cancerTONINI, Tiziana; ROSSI, Francesca; CLAUDIO, Pier Paolo et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6549-6556, issn 0950-9232, 8 p.Article

Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instabilityLAVIA, Patrizia; MILEO, Anna Maria; GIORDANO, Antonio et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6508-6516, issn 0950-9232, 9 p.Article

Viruses and cancer: lessons from the human polyomavirus, JCVREISS, Krzysztof; KHALILI, Kamel.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6517-6523, issn 0950-9232, 7 p.Article

Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vesselsFONSATTI, Ester; ALTOMONTE, Maresa; NICOTRA, Maria Rita et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6557-6563, issn 0950-9232, 7 p.Article

The future of antisense therapy: combination with anticancer treatmentsBIROCCIO, Annamaria; LEONETTI, Carlo; ZUPI, Gabriella et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6579-6588, issn 0950-9232, 10 p.Article

Epigenetic targets for immune intervention in human malignanciesMAIO, Michele; CORAL, Sandra; FRATTA, Elisabetta et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6484-6488, issn 0950-9232, 5 p.Article

Ocular neovascularization: a valuable model systemCAMPOCHIARO, Peter Anthony; HACKETT, Sean Francis.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6537-6548, issn 0950-9232, 12 p.Article

Axis of evil: molecular mechanisms of cancer metastasisBOGENRIEDER, Thomas; HERLYN, Meenhard.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6524-6536, issn 0950-9232, 13 p.Article

Small-molecule cyclin-dependent kinase modulatorsSENDEROWICZ, Adrian M.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6609-6620, issn 0950-9232, 12 p.Article

Genetic and epigenetic alterations as hallmarks of the intricate road to cancerMACALUSO, Marcella; PAGGI, Marco G; GIORDANO, Antonio et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6472-6478, issn 0950-9232, 7 p.Article

Advantages and limitations of microarray technology in human cancerRUSSOL, Giuseppe; ZEGARL, Charles; GIORDANO, Antonio et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6497-6507, issn 0950-9232, 11 p.Article

Treatment of non-small-cell lung cancer: state of the art and development of new biologic agentsGRIDELLI, Cesare; ROSSI, Antonio; MAIONE, Paolo et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6629-6638, issn 0950-9232, 10 p.Article

Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?ALTOMONTE, Maresa; FONSATTI, Ester; VISINTIN, Alberto et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6564-6569, issn 0950-9232, 6 p.Article

Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptorSURMACZ, Eva.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6589-6597, issn 0950-9232, 9 p.Article

Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agentsNICKOLOFF, Brian J; OSBORNE, Barbara A; MIELE, Lucio et al.Oncogene (Basingstoke). 2003, Vol 22, Num 42, pp 6598-6608, issn 0950-9232, 11 p.Article